Get the Stockscreener App
126.36
1.13%
1.41
After Hours:
126.36
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $126.36, with a volume of 5.17M.
It is up +1.13% in the last 24 hours and down -5.01% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$124.95
Open:
$125.64
24h Volume:
5.17M
Relative Volume:
0.91
Market Cap:
$219.92B
Revenue:
$43.84B
Net Income/Loss:
$13.90B
P/E Ratio:
15.85
EPS:
7.9725
Net Cash Flow:
$6.92B
1W Performance:
+2.22%
1M Performance:
-5.01%
6M Performance:
-5.67%
1Y Performance:
+9.59%
1-Day Range:
$124.65
$126.62
1-Week Range:
$122.44
$126.71
52-Week Range:
$110.86
$140.84
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3455 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-25 | Initiated | The Benchmark Company | Buy |
| Jul-18-25 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-25 | Initiated | Leerink Partners | Market Perform |
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Christine Poole's Top Picks: Abbott Labs, CN Rail & Otis Worldwide - BNN Bloomberg
Abbott Laboratories (ABT): Exploring Valuation After Mixed Q3 Earnings and Bullish Analyst Sentiment - simplywall.st
Infant Formula Market to Worth USD 207.19 Billion by 2034, Driven by Urbanization and Growing Demand for Convenient Nutrition Solutions - GlobeNewswire Inc.
U.S. Functional Protein Market to Get an Explosive Growth| - openPR.com
Abbott Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Sentiment analysis tools applied to Abbott LaboratoriesMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Is a relief rally coming for Abbott Laboratories holdersWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Abbott Laboratories stock benefit from infrastructure spendingQuarterly Investment Review & Expert Approved Momentum Trade Ideas - fcp.pa.gov.br
Why Abbott Laboratories (Common Stock) (ABL0) stock is a must watch tickerMarket Activity Recap & AI Optimized Trade Strategies - newser.com
Has Abbott Stock’s Valuation Shifted With Expanded FDA Approvals in 2025? - Yahoo! Finance UK
Why Abbott Laboratories (ABL) stock could outperform next yearQuarterly Trade Report & Expert Curated Trade Ideas - fcp.pa.gov.br
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Abbott Laboratories $ABT Stock Holdings Boosted by Dillon & Associates Inc. - MarketBeat
Tufton Capital Management Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Huntington National Bank Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Will earnings trigger a reversal in Abbott LaboratoriesWeekly Profit Analysis & Community Supported Trade Ideas - newser.com
Commonwealth Retirement Investments LLC Acquires Shares of 20,274 Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories' (NYSE:ABT) Earnings Are Weaker Than They Seem - simplywall.st
Jacobson & Schmitt Advisors LLC Acquires Shares of 2,827 Abbott Laboratories $ABT - MarketBeat
Is Abbott Laboratories stock a buy on dipsJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com
Bank of New York Mellon Corp Cuts Position in Abbott Laboratories $ABT - MarketBeat
With 80% ownership, Abbott Laboratories (NYSE:ABT) boasts of strong institutional backing - Yahoo Finance
Freestone Capital Holdings LLC Cuts Holdings in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories stock trades during market volatility2025 Market Outlook & Smart Money Movement Tracker - newser.com
Is Abbott Laboratories showing signs of accumulation2025 Valuation Update & Precise Buy Zone Identification - newser.com
Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & SuppliesDiversified Stocks - Barchart.com
How geopolitical tensions affect Abbott Laboratories stockJuly 2025 Patterns & Real-Time Buy Signal Alerts - fcp.pa.gov.br
Abbott Laboratories (NYSE:ABT) Is Favoured by Institutional Owners Who Hold 80% of the Company - 富途牛牛
Abbott Laboratories $ABT Shares Bought by State of Michigan Retirement System - MarketBeat
Is Abbott Laboratories a candidate for recovery play2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
SS&H Financial Advisors Inc. Grows Stake in Abbott Laboratories $ABT - MarketBeat
Tredje AP fonden Has $109.24 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Holdings Lifted by Tsfg LLC - MarketBeat
iA Global Asset Management Inc. Reduces Position in Abbott Laboratories $ABT - MarketBeat
AlphaStar Capital Management LLC Buys Shares of 2,245 Abbott Laboratories $ABT - MarketBeat
Is Abbott Laboratories stock a buy in volatile marketsTrade Entry Report & Reliable Price Breakout Signals - newser.com
Greater Midwest Financial Group LLC Buys 18,927 Shares of Abbott Laboratories $ABT - MarketBeat
Syverson Strege & Co Acquires 2,723 Shares of Abbott Laboratories $ABT - MarketBeat
Integrity Alliance LLC. Reduces Position in Abbott Laboratories $ABT - MarketBeat
Assetmark Inc. Grows Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Spire Wealth Management - MarketBeat
Abbott Laboratories $ABT Shares Sold by Fisher Funds Management LTD - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Linscomb Wealth Inc. - MarketBeat
How Abbott Laboratories stock reacts to inflationary pressuresMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Technical signs of recovery in Abbott LaboratoriesWatch List & Trade Opportunity Analysis - newser.com
Looking at the Narrative for Abbott as Legal Wins and Device Growth Shift the Outlook - Yahoo Finance
Simon Quick Advisors LLC Buys 4,430 Shares of Abbott Laboratories $ABT - MarketBeat
Strs Ohio Raises Stake in Abbott Laboratories $ABT - MarketBeat
Amalgamated Bank Purchases 21,362 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Atria Investments Inc - MarketBeat
Abbott Laboratories $ABT Shares Sold by Keybank National Association OH - MarketBeat
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):